It is known that afatinib resistant NCI-H1975 tumor clones showed lower PTEN expression levels than control clones, suggesting the decreased PTEN expression might contribute to the resistance to EGFR-TKI therapy [32,35]. This evidence concerns the gene EGFR and neoplasm.